ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
129.480,89
0,21%
S&P 500
5.187,67
0,00%
US Dollar vs BRL
5,0892
0,00%
Bitcoin
61.655,09
0,76%
Brent Oil
83,725
0,20%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. Baxalta Incorporated (BXLT)

  7. Baxalta Incorporated (BXLT) Notícias

BXLT

Baxalta Incorporated (BXLT)

Baxalta Incorporated
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:BXLT
DataHoraFonteTítuloCódigoCompanhia
07/02/201919:30Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 13 and 15(d) (15-15d)NYSE:BXLTBaxalta Incorporated
28/06/201616:50Edgar (US Regulatory)Annual Report of Employee Stock Plans (11-k)NYSE:BXLTBaxalta Incorporated
13/06/201617:26Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NYSE:BXLTBaxalta Incorporated
07/06/201617:51Edgar (US Regulatory)Statement of Ownership (sc 13g)NYSE:BXLTBaxalta Incorporated
07/06/201617:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:BXLTBaxalta Incorporated
03/06/201617:23Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NYSE:BXLTBaxalta Incorporated
03/06/201617:14Edgar (US Regulatory)Current Report Filing (8-k)NYSE:BXLTBaxalta Incorporated
03/06/201615:41Edgar (US Regulatory)(25-NSE)NYSE:BXLTBaxalta Incorporated
03/06/201604:40PR Newswire (US)Shire Completes Combination With Baxalta Creating the Global Leader in Rare Diseases and Highly Specialized ConditionsNYSE:BXLTBaxalta Incorporated
27/05/201618:50PR Newswire (US)TransDigm Group Set to Join the S&P 500; Helen of Troy and Brocade Communications Systems to Join S&P MidCap 400; Team and MD...NYSE:BXLTBaxalta Incorporated
27/05/201618:23Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NYSE:BXLTBaxalta Incorporated
27/05/201617:17Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:BXLTBaxalta Incorporated
27/05/201613:55Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NYSE:BXLTBaxalta Incorporated
27/05/201611:00Business WireCORRECTING and REPLACING Baxalta Shareholders Vote to Approve CombinationNYSE:BXLTBaxalta Incorporated
27/05/201609:59Business WireBaxalta Shareholders Vote to Approve CombinationNYSE:BXLTBaxalta Incorporated
27/05/201605:47Dow Jones NewsShire Shareholders Approve $32 Billion Baxalta Merger; Deal Expected to Close June 3NYSE:BXLTBaxalta Incorporated
26/05/201608:00Business WireOncoResponse Secures Investment from BaxaltaNYSE:BXLTBaxalta Incorporated
25/05/201607:45Business WireBaxalta Reports Positive Phase 1 Results for BAX 930, Investigational Recombinant ADAMTS13 to Treat Hereditary Thrombotic Thr...NYSE:BXLTBaxalta Incorporated
24/05/201621:00Business WireThunderbolt Pharma, Inc., a Vitesse Biologics Company, Acquires Rights to BAFF/APRIL Dual Antagonist Program from Astellas Ph...NYSE:BXLTBaxalta Incorporated
23/05/201609:00Business WireBaxalta Announces Preliminary Merger Consideration Election ResultsNYSE:BXLTBaxalta Incorporated
20/05/201617:44Edgar (US Regulatory)Specialized Disclosure Report (sd)NYSE:BXLTBaxalta Incorporated
19/05/201608:00PR Newswire (US)Merrimack and Baxalta Announce Initiation of Phase 1 Study of MM-151 in Combination with the ONIVYDE® (irinotecan liposome i...NYSE:BXLTBaxalta Incorporated
16/05/201607:01Edgar (US Regulatory)Notice of Effectiveness (effect)NYSE:BXLTBaxalta Incorporated
13/05/201618:33Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NYSE:BXLTBaxalta Incorporated
12/05/201618:39Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NYSE:BXLTBaxalta Incorporated
10/05/201617:01Business WireBaxalta Declares Quarterly DividendNYSE:BXLTBaxalta Incorporated
09/05/201619:10Edgar (US Regulatory)Quarterly Report (10-q)NYSE:BXLTBaxalta Incorporated
04/05/201618:25Business WireBaxter Increases the Size of Its Previously Announced Offer to Exchange Shares of Baxter for Shares of BaxaltaNYSE:BXLTBaxalta Incorporated
02/05/201607:45Business WireBaxalta Receives Positive Opinion from Europe’s CHMP for HYQVIA to Treat Pediatric PatientsNYSE:BXLTBaxalta Incorporated
29/04/201610:20Dow Jones NewsShire Posts First-Quarter Profit, Revenue GrowthNYSE:BXLTBaxalta Incorporated
 Apresentando as notícias mais relevantes sobre:NYSE:BXLT

Seu Histórico Recente

BOV
COGN3
COGNA ON
BOV
IBOV
Índice Bovespa
BOV
VVEO3
CM Hospitalar ON
BOV
JHSF3
JHSF PART ON
BOV
OIBR3
OI ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
SGPS3
SPRINGS ON
BOV
ENAT3
ENAUTA ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
BRKM5
BRASKEM PNA
BOV
HBRE3
HBR Realty Empreendiment... ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados